Research Study

Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study
Principal Investigator 
Jan P. Dutz

Overview

Body Locations and Systems 
Psoriasis
ClinicalTrials.gov# 
NCT02196701
Status 
Recruiting
Study Start/End 
Oct 28, 2014 to Jun 30, 2017
Locations 
Vancouver General Hospital
Name/Title 
Jaspal Mor, Research Coordinator
Phone 
604-875-5296
Purpose of Study 

The purpose of this study is to determine the safety and efficacy of the use of the combination therapy adalimumab (ADA) every other week (EOW) with methotrexate (MTX) in suboptimal responders to ADA monotherapy.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.